Intermittent montelukast in young children with wheeze showed no significant benefit when compared with placebo, according to study results. The number of unscheduled medical visits for wheezing ...

January 4, 2012 — In preschool-aged children, a 12-week course of treatment with the selective leukotriene receptor antagonist montelukast did not reduce the incidence of upper respiratory tract ...

Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trial. The Lancet Respiratory Medicine , 2014; DOI: 10.1016 ...

A study compared effectiveness of intermittent montelukast with placebo in reducing wheezing episodes in 1358 children aged 10 months to 5 years and whether genotype determined the patient outcome.

Perspective from Niels Rutjes, MD and Susanne Vijverberg, PhD Montelukast does not appear to increase the risk for neuropsychiatric adverse events in children and adolescents, according to a study ...

Children who have allergic asthma cough ... Your child can take these medicines as a syrup, chewable tablet, or nasal spray. Because some antihistamines cause drowsiness, you might want to ...

(HealthDay News) — For children with wheeze, intermittent montelukast is not associated with clear benefit, according to a study published online September 9 in The Lancet Respiratory Medicine ...

The asthma medication montelukast (Singulair, Merck) is linked to increased reports of depression and nightmares in adults and children, as well as aggression in children, according to a review of ...

This worrying pattern was especially prevalent in kids. In 2020 these reports prompted the Food and Drug Administration to issue Singulair and the generic versions of montelukast a serious label ...

A popular asthma tablet linked to cases of suicidal thoughts and depression in children will now be sold with side effect warnings inside its packaging. Warnings about side effects of Montelukast ...